Pharmacy sales specialist, Hutchings Consultants has revealed its market predictions for the next 12 months in a new report.
The broker is anticipating that both independent group operators and corporate owners will continue to reassess their existing portfolios in 2024, making strategic
disposals of varying sizes.
"This is likely to result in transaction volumes remaining high for the foreseeable future," stated the report authored by Paul Steet, Associate Director, Hutchings
Consultants.
Community Pharmacy Contractual Framework negotiations will be the most notable opportunity for the sector to capitalise upon this year, the broker said, adding that
it's "a belated opportunity for the sector to secure a vital uplift to the contract's fixed global sum."